The Biosimilar Advantage: Powering patient access and industrial resilience

7 May 2026

Leading manufacturers appeal in proceedings against discriminatory wastewater fees on medicine before European Court of Justice

27 April 2026

Gemme is transforming and becoming ALMA – Alliance des Médicaments Abordables

15 April 2026

Open Letter on Critical Medicines Act trilogues negotations – The CMA must deliver on EU health security

10 March 2026

New EU Pharma Legislation to safeguard patient access and boost off-patent medicines efficiency

26 February 2026

Call to ‘Stop the Clock’ on UWWTD – Urgent reassessment needed to protect competitiveness and supply

25 February 2026

Press statement on UWWTD Court Decision

20 February 2026

EU policies must not push essential medicines off market: new Medicines for Europe president

9 February 2026

President Steffen Saltofte argues that EU policy must protect timely […]

‘Access Is A Right, Not A Privilege’ – Medicines For Europe’s Saltofte Sets Out Priorities

9 February 2026

The president of Medicines for Europe, Steffen Saltofte, says Medicines […]

Overview of the pilots in Europe testing the use of the electronic product information (ePI) for medicines

9 February 2026